LYSARC,
Academic partner
of Lymphoma
Clinical Research

Lymphoma Expertise

LYSARC has the skills, experience and means for conducting phase 1 (including first-in-man), 2, 3 (including international, pivotal, registration studies) and 4 clinical trials.

It also has the ability to implement a long-term post-protocol follow-up (survival, late toxicities) of patients in these studies.

From its databases, LYSARC can perform retrospective studies: clinical-biological correlations, subpopulation studies, meta-analyzes.

LYSARC also contributes operationally to ancillary projects in biology, histopathology or imaging, decided by LYSA, from the clinical studies it conducts.